Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights

Author:

Nagy-Szakal Dorottya12,Couto-Rodriguez Mara1,Wells Heather L.1,Barrows Joseph E.1,Debieu Marilyne1,Butcher Kristin3,Chen Siyuan3,Berki Agnes4,Hager Courteny1,Boorstein Robert J.5,Taylor Mariah K.6,Jonsson Colleen B.6ORCID,Mason Christopher E.178910,O’Hara Niamh B.1211ORCID

Affiliation:

1. Biotia, Inc., New York, New York, USA

2. Department of Cell Biology, College of Medicine, SUNY Downstate Health Sciences University, New York, New York, USA

3. Twist Bioscience, South San Francisco, California, USA

4. School of Natural Sciences, College of Natural, Behavioral and Health Sciences, Caldwell University, Caldwell, New Jersey, USA

5. Lenco Diagnostic Laboratories, Inc., New York, New York, USA

6. The University of Tennessee Health Science Center, Memphis, Tennessee, USA

7. Tri-Institutional Computational Biology & Medicine Program, Weill Cornell Medicine, Cornell University, New York, New York, USA

8. HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York, USA

9. WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine, New York, New York, USA

10. Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York, USA

11. Jacobs Technion-Cornell Institute, Cornell Tech, New York, New York, USA

Abstract

This is the first FDA emergency-use-authorized hybridization capture-based next-generation sequencing (NGS) assay to detect the SARS-CoV-2 genome. Viral metagenomics and the novel hybrid capture NGS-based assay, along with its research-use-only analysis, can provide important genetic insights into SARS-CoV-2 and other emerging pathogens and improve surveillance and early detection, potentially preventing or mitigating new outbreaks.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3